Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Global Market Report 2026

Description

Messenger ribonucleic acid (mRNA) and next-generation vaccine platforms denote advanced vaccine technologies that utilize genetic instructions, including mRNA, DNA, or viral vectors, to activate the body's immune system to produce protective proteins and establish immunity against diseases. These platforms facilitate faster vaccine development, high adaptability to emerging pathogens, scalable production, and enhanced immune responses compared to conventional vaccine methods.

The primary vaccine types of messenger ribonucleic acid (mRNA) and next-generation vaccine platforms include messenger ribonucleic acid vaccines, deoxyribonucleic acid (DNA) vaccines, viral vector vaccines, protein subunit vaccines, peptide vaccines, and other vaccine types. Messenger ribonucleic acid (mRNA) vaccines utilize synthetic mRNA sequences to instruct cells to produce specific antigens, thereby initiating an immune response against a target pathogen or disease. These platforms employ technologies including lipid nanoparticle (LNP) delivery, self-amplifying mRNA (saRNA), circular mRNA (circRNA), replicon or non-replicating platforms, and viral vector technologies. They are applied for disease indications including infectious diseases, oncology, rare diseases, and other medical conditions, and end users include pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and research institutes, and hospitals and clinics.

Tariffs on bioprocess equipment, lipid materials, specialized enzymes, and cold chain components are influencing the mrna and next generation vaccine platforms market by increasing production and scale up costs. Platform manufacturing and delivery system segments are most affected where imported reagents and processing systems are widely used, especially in north america and europe. Higher import costs can raise vaccine development and commercialization budgets. However, tariffs are also encouraging local sourcing of raw materials and regional biomanufacturing capacity expansion. This supports domestic platform developers and regional vaccine supply chains.

The messenger ribonucleic acid (mrna) and next-generation vaccine platforms market research report is one of a series of new reports from The Business Research Company that provides messenger ribonucleic acid (mrna) and next-generation vaccine platforms market statistics, including messenger ribonucleic acid (mrna) and next-generation vaccine platforms industry global market size, regional shares, competitors with a messenger ribonucleic acid (mrna) and next-generation vaccine platforms market share, detailed messenger ribonucleic acid (mrna) and next-generation vaccine platforms market segments, market trends and opportunities, and any further data you may need to thrive in the messenger ribonucleic acid (mrna) and next-generation vaccine platforms industry. This messenger ribonucleic acid (mrna) and next-generation vaccine platforms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The messenger ribonucleic acid (mrna) and next-generation vaccine platforms market size has grown rapidly in recent years. It will grow from $39.69 billion in 2025 to $45.88 billion in 2026 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to covid 19 vaccine breakthroughs, prior viral vector research, global pandemic preparedness programs, advances in genomic sequencing, early nucleic acid vaccine trials.

The messenger ribonucleic acid (mrna) and next-generation vaccine platforms market size is expected to see rapid growth in the next few years. It will grow to $82.61 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to growth of personalized cancer vaccines, expansion of infectious disease pipelines, faster platform based approvals, increased biotech funding, broader therapeutic vaccine use. Major trends in the forecast period include self amplifying mrna platforms, lipid nanoparticle delivery optimization, modular vaccine platform design, rapid pathogen target adaptation, next generation adjuvant systems.

The increasing demand for personalized medicine is anticipated to drive the growth of the messenger ribonucleic acid (mRNA) and next-generation vaccine platforms market in the coming years. Personalized medicine refers to a medical approach in which disease prevention and treatment strategies are tailored based on an individual's genetic profile, molecular characteristics, and specific health conditions. The rising demand for personalized medicine is driven by the increasing prevalence of complex and chronic diseases, which require targeted and patient-specific therapeutic solutions to improve treatment efficacy and safety outcomes. Messenger ribonucleic acid (mRNA) and next-generation vaccine platforms support personalized medicine by enabling rapid, flexible, and highly specific vaccine and therapeutic designs that can be customized to individual genetic and disease profiles, supporting precision-based healthcare delivery. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the messenger ribonucleic acid (mRNA) and next-generation vaccine platforms market.

Companies operating in the mRNA and next-generation vaccine platforms market are focusing on developing next-generation mRNA-based COVID-19 vaccines to enhance immune durability, broaden variant coverage, and improve overall vaccine performance. Next-generation mRNA-based COVID-19 vaccines leverage improved mRNA engineering and delivery technologies to provide broader and more durable protection against existing and emerging SARS-CoV-2 variants and enhance safety, stability, and storage convenience while allowing rapid adaptation to viral evolution. For example, in June 2025, Moderna Inc., a US-based biotechnology company, introduced mNEXSPIKE, its next-generation COVID-19 vaccine designed to improve protection against circulating and emerging SARS-CoV-2 variants. The vaccine incorporates an updated spike protein antigen that more closely matches recent variants and aims to deliver enhanced immune durability and effectiveness, supporting ongoing COVID-19 prevention efforts and future booster strategies.

In July 2024, GlaxoSmithKline plc, a UK-based pharmaceutical and biotechnology company, partnered with CureVac N.V. to advance next-generation mRNA vaccines and accelerate development. The partnership aims to fortify GlaxoSmithKline's vaccine pipeline by gaining strategic control over next-generation mRNA programs and expediting their development and commercialization. CureVac N.V. is a Germany-based biotechnology company specializing in next-generation messenger ribonucleic acid-based Covid and flu vaccines.

Major companies operating in the messenger ribonucleic acid (mrna) and next-generation vaccine platforms market are Pfizer Inc., Sanofi S.A., AstraZeneca PLC, Thermo Fisher Scientific Inc., GSK plc, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company Limited, Moderna Inc., BioNTech SE, Novavax Inc., Walvax Biotechnology Co Ltd, Arcturus Therapeutics Inc, Gennova Biopharmaceuticals Ltd, Vaxxas Pty Ltd, Vaxart Inc, Ethris GmbH, The Biologicals and Vaccines Institute of Southern Africa Proprietary Limited, eTheRNA Immunotherapies NV, Stemirna Therapeutics Co Ltd, Primrose Bio Inc, Acuitas Therapeutics Inc, and Incepta Vaccine Ltd.

North America was the largest region in the messenger ribonucleic acid (mRNA) and next-generation vaccine platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) and next-generation vaccine platforms market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the messenger ribonucleic acid (mrna) and next-generation vaccine platforms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The messenger ribonucleic acid (mRNA) and next-generation vaccine platforms market includes sales of messenger ribonucleic acid vaccines, lipid nanoparticle delivery systems, viral vector vaccines, protein subunit vaccines, recombinant antigen vaccines, next-generation adjuvants, synthetic ribonucleic acid constructs, stabilized messenger ribonucleic acid formulations, immune response modulators, and nucleic acid-based vaccine platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses messenger ribonucleic acid (mrna) and next-generation vaccine platforms market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for messenger ribonucleic acid (mrna) and next-generation vaccine platforms ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The messenger ribonucleic acid (mrna) and next-generation vaccine platforms market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Vaccine Type: Messenger Ribonucleic Acid Vaccines; Deoxyribonucleic Acid (DNA) Vaccines; Viral Vector Vaccines; Protein Subunit Vaccines; Peptide Vaccines; Other Vaccine Types
2) By Technology or Platform: Lipid Nanoparticle (LNP) Delivery; Self-Amplifying Messenger Ribonucleic Acid; Circular Messenger Ribonucleic Acid; Replicon or Non-replicating Platforms; Viral Vector Technologies
3) By Disease Indication: Infectious Diseases; Oncology; Rare Diseases; Other Disease Indications
4) By End User: Pharmaceutical and Biotechnology Companies; Contract Research Organizations (CROs); Academic and Research Institutes; Hospitals and Clinics
Subsegments:
1) By Messenger Ribonucleic Acid Vaccines: Conventional Messenger Ribonucleic Acid Vaccines; Self Amplifying Messenger Ribonucleic Acid Vaccines; Modified Messenger Ribonucleic Acid Vaccines; Circular Messenger Ribonucleic Acid Vaccines
2) By Deoxyribonucleic Acid Vaccines: Plasmid Deoxyribonucleic Acid Vaccines; Viral Assisted Deoxyribonucleic Acid Vaccines; Synthetic Deoxyribonucleic Acid Vaccines; Gene Based Deoxyribonucleic Acid Vaccines
3) By Viral Vector Vaccines: Adenovirus Based Viral Vector Vaccines; Lentivirus Based Viral Vector Vaccines; Poxvirus Based Viral Vector Vaccines; Measles Virus Based Viral Vector Vaccines
4) By Protein Subunit Vaccines: Recombinant Protein Vaccines; Virus Like Particle Vaccines; Toxoid Based Protein Vaccines; Polysaccharide Conjugate Vaccines
5) By Peptide Vaccines: Synthetic Peptide Vaccines; Personalized Peptide Vaccines; Multi Epitope Peptide Vaccines; Long Peptide Vaccines
6) By Other Vaccine Types: Protein Subunit Vaccines, Virus-Like Particle Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vector Vaccines
Companies Mentioned: Pfizer Inc.; Sanofi S.A.; AstraZeneca PLC; Thermo Fisher Scientific Inc.; GSK plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company Limited; Moderna Inc.; BioNTech SE; Novavax Inc.; Walvax Biotechnology Co Ltd; Arcturus Therapeutics Inc; Gennova Biopharmaceuticals Ltd; Vaxxas Pty Ltd; Vaxart Inc; Ethris GmbH; The Biologicals and Vaccines Institute of Southern Africa Proprietary Limited; eTheRNA Immunotherapies NV; Stemirna Therapeutics Co Ltd; Primrose Bio Inc; Acuitas Therapeutics Inc; and Incepta Vaccine Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH3MMRAM05_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Artificial Intelligence & Autonomous Intelligence
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.5 Sustainability, Climate Tech & Circular Economy
4.2. Major Trends
- 4.2.1 Self Amplifying Mrna Platforms
- 4.2.2 Lipid Nanoparticle Delivery Optimization
- 4.2.3 Modular Vaccine Platform Design
- 4.2.4 Rapid Pathogen Target Adaptation
- 4.2.5 Next Generation Adjuvant Systems

5. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Analysis Of End Use Industries

5.1 Pharmaceutical And Biotechnology Companies
5.2 Contract Research Organizations (Cros)
5.3 Academic And Research Institutes
5.4 Hospitals And Clinics
5.5 Government Vaccine Programs

6. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Size, Comparisons And Growth Rate Analysis
7.3. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Segmentation

9.1. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Messenger Ribonucleic Acid Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Viral Vector Vaccines, Protein Subunit Vaccines, Peptide Vaccines, Other Vaccine Types
9.2. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Lipid Nanoparticle (LNP) Delivery, Self-Amplifying Messenger Ribonucleic Acid, Circular Messenger Ribonucleic Acid, Replicon or Non-replicating Platforms, Viral Vector Technologies
9.3. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Infectious Diseases, Oncology, Rare Diseases, Other Disease Indications
9.4. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes, Hospitals and Clinics
9.5. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Messenger Ribonucleic Acid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Conventional Messenger Ribonucleic Acid Vaccines, Self Amplifying Messenger Ribonucleic Acid Vaccines, Modified Messenger Ribonucleic Acid Vaccines, Circular Messenger Ribonucleic Acid Vaccines
9.6. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Deoxyribonucleic Acid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Plasmid Deoxyribonucleic Acid Vaccines, Viral Assisted Deoxyribonucleic Acid Vaccines, Synthetic Deoxyribonucleic Acid Vaccines, Gene Based Deoxyribonucleic Acid Vaccines
9.7. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Viral Vector Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Adenovirus Based Viral Vector Vaccines, Lentivirus Based Viral Vector Vaccines, Poxvirus Based Viral Vector Vaccines, Measles Virus Based Viral Vector Vaccines
9.8. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Protein Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Recombinant Protein Vaccines, Virus Like Particle Vaccines, Toxoid Based Protein Vaccines, Polysaccharide Conjugate Vaccines
9.9. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Peptide Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Synthetic Peptide Vaccines, Personalized Peptide Vaccines, Multi Epitope Peptide Vaccines, Long Peptide Vaccines
9.10. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Protein Subunit Vaccines, Virus-Like Particle Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vector Vaccines

10. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Regional And Country Analysis

10.1. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

11.1. Asia-Pacific Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

12.1. China Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

13.1. India Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

14.1. Japan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

15.1. Australia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

16.1. Indonesia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

17.1. South Korea Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

18.1. Taiwan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

19.1. South East Asia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

20.1. Western Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

21.1. UK Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

22.1. Germany Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

23.1. France Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

24.1. Italy Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

25.1. Spain Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

26.1. Eastern Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

27.1. Russia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

28.1. North America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

29.1. USA Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

30.1. Canada Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

31.1. South America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

32.1. Brazil Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

33.1. Middle East Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

34.1. Africa Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Regulatory and Investment Landscape

36. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Competitive Landscape And Company Profiles

36.1. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Company Profiles
- 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis

37. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Other Major And Innovative Companies

Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company Limited, Moderna Inc., BioNTech SE, Novavax Inc., Walvax Biotechnology Co Ltd, Arcturus Therapeutics Inc, Gennova Biopharmaceuticals Ltd, Vaxxas Pty Ltd, Vaxart Inc, Ethris GmbH, The Biologicals and Vaccines Institute of Southern Africa Proprietary Limited, eTheRNA Immunotherapies NV, Stemirna Therapeutics Co Ltd, Primrose Bio Inc

38. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

41. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market High Potential Countries, Segments and Strategies

41.1 Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market In 2030 - Countries Offering Most New Opportunities
41.2 Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market In 2030 - Segments Offering Most New Opportunities
41.3 Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market In 2030 - Growth Strategies
- 41.3.1 Market Trend Based Strategies
- 41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations
42.2. Currencies
42.3. Historic And Forecast Inflation Rates
42.4. Research Inquiries
42.5. The Business Research Company
42.6. Copyright And Disclaimer